Cargando…
Impaired fibrinolysis in critically ill COVID-19 patients
BACKGROUND: Critically ill coronavirus disease 2019 (COVID-19) patients present with a hypercoagulable state with high rates of macrovascular and microvascular thrombosis, for which hypofibrinolysis might be an important contributing factor. METHODS: We retrospectively analysed 20 critically ill COV...
Autores principales: | Bachler, Mirjam, Bösch, Johannes, Stürzel, Daniel P., Hell, Tobias, Giebl, Andreas, Ströhle, Mathias, Klein, Sebastian J., Schäfer, Volker, Lehner, Georg F., Joannidis, Michael, Thomé, Claudius, Fries, Dietmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833514/ https://www.ncbi.nlm.nih.gov/pubmed/33422287 http://dx.doi.org/10.1016/j.bja.2020.12.010 |
Ejemplares similares
-
Unrecognized diabetes in critically ill COVID-19 patients
por: Klein, Sebastian J., et al.
Publicado: (2020) -
Progression of Fibrinogen Decrease during High Dose Tigecycline Therapy in Critically Ill Patients: A Retrospective Analysis
por: Treml, Benedikt, et al.
Publicado: (2021) -
A Prospective Pilot Trial to Assess the Efficacy of Argatroban (Argatra(®)) in Critically Ill Patients with Heparin Resistance †
por: Bachler, Mirjam, et al.
Publicado: (2020) -
Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients
por: Bachler, Mirjam, et al.
Publicado: (2019) -
Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective ‘Genetic’ Matched Analysis
por: Rugg, Christopher, et al.
Publicado: (2020)